Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDC42BPG | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
mRNA | TINAGL1 | CCLE | pan-cancer | AAC | 0.2 | 0.0005 |
mRNA | HBG1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | GPR176 | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |
mRNA | TMC6 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
mRNA | SAMSN1 | CCLE | pan-cancer | AAC | 0.22 | 0.0005 |
mRNA | NCOA4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | PAEP | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
mRNA | CDC42 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
mRNA | PSMB8 | FIMM | pan-cancer | AAC | -0.66 | 0.0005 |